ESTRO 2024 - Abstract Book

S1986

Clinical - Mixed sites, palliation

ESTRO 2024

of LC and follow-up schedules, detailed time to event data, as well as more information about the delivered radiation dose distribution.

Keywords: SBRT, spine, metastases

References:

McGee HM, Carpenter TJ, Ozbek U, Kirkwood KA, Tseng TC, Blacksburg S, Germano IM, Green S, Buckstein M. Analysis of Local Control and Pain Control After Spine Stereotactic Radiosurgery Reveals Inferior Outcomes for Hepatocellular Carcinoma Compared With Other Radioresistant Histologies. Pract Radiat Oncol. 2019 Mar;9(2):89 97. doi: 10.1016/j.prro.2018.11.009. Epub 2018 Dec 10. PMID: 30543868. Ito K, Yamaguchi T, Ogawa H, Nakajima Y, Karasawa K. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer. Jpn J Clin Oncol. 2020 Dec 16;50(12):1442-1446. doi: 10.1093/jjco/hyaa128. PMID: 32719860. Soltys SG, Grimm J, Milano MT, Xue J, Sahgal A, Yorke E, Yamada Y, Ding GX, Li XA, Lovelock DM, Jackson A, Ma L, El Naqa I, Gibbs IC, Marks LB, Benedict S. Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):112 123. doi: 10.1016/j.ijrobp.2020.11.021. Epub 2021 Jan 27. PMID: 33516580. Yamada Y, Katsoulakis E, Laufer I, Lovelock M, Barzilai O, McLaughlin LA, Zhang Z, Schmitt AM, Higginson DS, Lis E, Zelefsky MJ, Mechalakos J, Bilsky MH. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus. 2017 Jan;42(1):E6. doi: 10.3171/2016.9.FOCUS16369. PMID: 28041329; PMCID: PMC5568686. Ryu S, Deshmukh S, Timmerman RD, Movsas B, Gerszten P, Yin FF, Dicker A, Abraham CD, Zhong J, Shiao SL, Tuli R, Desai A, Mell LK, Iyengar P, Hitchcock YJ, Allen AM, Burton S, Brown D, Sharp HJ, Dunlap NE, Siddiqui MS, Chen TH, Pugh SL, Kachnic LA. Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. JAMA Oncol. 2023 Jun 1;9(6):800 807. doi: 10.1001/jamaoncol.2023.0356. PMID: 37079324; PMCID: PMC10119775. Zeng KL, Abugarib A, Soliman H, Myrehaug S, Husain ZA, Detsky J, Ruschin M, Karotki A, Atenafu EG, Larouche J, Campbell M, Maralani P, Sahgal A, Tseng CL. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):686-695. doi: 10.1016/j.ijrobp.2022.09.076. Epub 2022 Oct 26. PMID: 36309076.

2730

Poster Discussion

Utilisation of radiotherapy in the English NHS: A national radiotherapy dataset analysis

Katie L Spencer 1,2,3 , Alex Kao 3 , Catherine Roe 3 , Katherine Thackray 3 , Georgios Lyratzopoulos 4 , Daniela Tataru 3